共 50 条
- [1] Gemtuzumab ozogamicin (Mylotarg®) in children with refractory or relapsed acute myeloid leukemia [J]. ONKOLOGIE, 2004, 27 (03): : 269 - 272
- [6] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience [J]. International Journal of Hematology, 2021, 113 : 362 - 369
- [9] Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children-the Polish Pediatric Leukemia and Lymphoma Study Group experience [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14